Prednisolone Acetate Eye Drops Manufacturer in India

Prednisolone 1% eye drops are the standard corticosteroid used for: post-operative inflammation after cataract surgery and other intraocular procedures, anterior uveitis management, allergic conjunctivitis with significant inflammatory component, episcleritis and scleritis, vernal keratoconjunctivitis, and sympathetic ophthalmia. The 0.5% strength is used for milder inflammatory conditions and in patients with higher steroid response risk.

Prednisolone 1% is the standard strength for significant intraocular inflammation — post-cataract surgery, uveitis and severe allergic eye disease. Prednisolone 0.5% is used for milder inflammatory conditions, for tapering at the end of a treatment course, and in patients at higher risk of steroid-induced intraocular pressure elevation. Both strengths are available from 9M India with the same complete GMP documentation.

Yes. Prednisolone Sodium Phosphate 1% eye drops are the most widely used post-operative anti- inflammatory agent after phacoemulsification (cataract surgery). The standard regimen is typically 4 times daily for 4 weeks post-surgery, tapering to twice daily for a further 2 weeks. Cataract surgery is performed at enormous volume globally — over 10 million procedures annually in India alone — making Prednisolone eye drops a consistently high-volume institutional procurement item.

Yes. Prednisolone eye drops are a core part of 9M India's institutional ophthalmic supply portfolio. We supply to hospital ophthalmic departments and government cataract surgery programmes. Large-volume institutional packaging with complete GMP documentation, CoPP and batch CoA is available. Please contact our export team with programme volume requirements.

Prolonged corticosteroid eye drop use carries risks including steroid-induced ocular hypertension (elevated IOP leading to secondary glaucoma), posterior subcapsular cataract formation, and reduced resistance to ocular infections. These are well-documented risks that ophthalmologists manage with regular IOP monitoring, appropriate duration of use and steroid selection. These risks are relevant for clinical prescribing — not for the supply or registration of the formulation.

Yes. 9M India manufactures Moxifloxacin + Prednisolone Acetate combination eye drops — combining broad-spectrum antibiotic cover with corticosteroid anti-inflammatory action in a single formulation. This combination is widely used post-operatively after cataract surgery and in bacterial keratitis with inflammatory component, simplifying the post-operative drop regimen.

Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, CoPP, batch- wise CoA (sterility, particulate matter, pH, assay, preservative content), ICH Zone IVb stability data and CTD/ACTD dossiers on request. Prednisolone eye drops are one of our highest-volume export formulations with established dossiers for multiple markets.